N/a.; N/a.
Introduction: We sought to evaluate if internal medicineoutpatients are candidates to COMPASS trial strategy (lowdose rivaroxaban twice a day plus daily acetylsalicylic acid),to detail the inclusion and exclusion criteria of COMPASS trial presented by internal medicine patients and to evaluate the frequency of patients already under the strategy. Methods: Observational, retrospective, and transversalstudy in an...
N/a.; N/a.